Keyphrases
RhoC
100%
Malignant Cancer
40%
Assay System
40%
Effector Domain
20%
Therapeutic Agents
20%
Effector Binding
20%
Small Molecules
20%
Small Molecule Compounds
20%
Rho GTPases
20%
High Signal-to-noise Ratio
20%
Unknown Target
20%
Cancerous Transformation
20%
Protein Microenvironments
20%
Prognostic Indicator
20%
Therapeutic Intervention
20%
High-throughput Screening Assays
20%
Screening Strategy
20%
High-throughput Screening
20%
Cancer Malignancy
20%
Guanine nucleotide Exchange Factor
20%
Guanine nucleotide
20%
Multiplex
20%
Solvatochromic Dyes
20%
Novel Assay
20%
Cancer Metastasis
20%
Nucleotide State
20%
Expression Level
20%
Coefficient of Variation
20%
Rho Family GTPases
20%
Medicine and Dentistry
Malignant Neoplasm
100%
High Throughput Screening
100%
Guanine Nucleotide Exchange Factor
50%
Signal-to-Noise Ratio
50%
Rho Guanine Nucleotide Binding Protein
50%
Metastatic Carcinoma
50%
Guanine Nucleotide
50%
Cancer
50%
Carcinogenesis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
High-Throughput Screening
100%
Rho Guanine Nucleotide Binding Protein
50%
Guanine Nucleotide
50%
Guanine Nucleotide Exchange Factor
50%
Carcinogenesis
50%